DK1190101T3 - Sammensætninger og fremgangsmåder til at forebygge transepithelial overförsel af HIV - Google Patents

Sammensætninger og fremgangsmåder til at forebygge transepithelial overförsel af HIV

Info

Publication number
DK1190101T3
DK1190101T3 DK00944817T DK00944817T DK1190101T3 DK 1190101 T3 DK1190101 T3 DK 1190101T3 DK 00944817 T DK00944817 T DK 00944817T DK 00944817 T DK00944817 T DK 00944817T DK 1190101 T3 DK1190101 T3 DK 1190101T3
Authority
DK
Denmark
Prior art keywords
icam
hiv
compositions
methods
transmission
Prior art date
Application number
DK00944817T
Other languages
Danish (da)
English (en)
Inventor
Richard B Markham
Kristen V Khanna
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of DK1190101T3 publication Critical patent/DK1190101T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK00944817T 1999-06-24 2000-06-23 Sammensætninger og fremgangsmåder til at forebygge transepithelial overförsel af HIV DK1190101T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14069899P 1999-06-24 1999-06-24
PCT/US2000/017293 WO2000079010A1 (en) 1999-06-24 2000-06-23 Compositions and methods for preventing transepithelial transmission of hiv

Publications (1)

Publication Number Publication Date
DK1190101T3 true DK1190101T3 (da) 2009-08-03

Family

ID=22492418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00944817T DK1190101T3 (da) 1999-06-24 2000-06-23 Sammensætninger og fremgangsmåder til at forebygge transepithelial overförsel af HIV

Country Status (11)

Country Link
US (1) US6566095B1 (de)
EP (1) EP1190101B1 (de)
JP (1) JP4880153B2 (de)
CN (2) CN1402797A (de)
AT (1) ATE429518T1 (de)
AU (1) AU777241B2 (de)
CA (1) CA2377479C (de)
DE (1) DE60042069D1 (de)
DK (1) DK1190101T3 (de)
HK (1) HK1047300A1 (de)
WO (1) WO2000079010A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545007B2 (en) * 2000-11-17 2003-04-08 Idenix (Cayman) Limited Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines
US20060063828A1 (en) * 2004-06-28 2006-03-23 Weingarten M D 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
WO2007047573A2 (en) 2005-10-14 2007-04-26 The Johns Hopkins School Of Medicine Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods
RU2594249C2 (ru) * 2010-04-09 2016-08-10 Иммурон Лимитед Способы и композиции для предотвращения передачи вич-инфекции
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US20120100186A1 (en) * 2010-10-20 2012-04-26 Washington University Nanoparticulate-based contraceptive/anti-hiv composition and methods
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284931A (en) 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
ATE219838T1 (de) 1989-03-16 2002-07-15 Blood Res Center Verwendung von funktionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie
WO1990013281A2 (en) 1989-04-28 1990-11-15 Baylor College Of Medicine Method of suppressing hiv infection
AU5553290A (en) 1989-04-28 1990-11-29 Baylor College Of Medicine Dissemination of hiv-1 infected cells
US5324510A (en) 1989-09-01 1994-06-28 Boehringer Ingelheim Pharmaceuticals, Inc. Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma
GB9009549D0 (en) 1990-04-27 1990-06-20 Celltech Ltd Recombinant antibody and method
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
US5686581A (en) 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5629162A (en) * 1991-06-11 1997-05-13 The Center For Blood Research Method of identifying agents which modulate ICAM-3 binding to LFA-1
US5532127A (en) 1992-01-27 1996-07-02 Icos Corporation Assay for 1-CAM related protein expression
US5525487A (en) 1992-01-27 1996-06-11 Icos Corporation DNA encoding I-CAM related protein
JP3616090B2 (ja) 1992-01-27 2005-02-02 イコス コーポレイション 細胞間接着分子関連タンパク質
ATE209040T1 (de) * 1992-06-11 2001-12-15 Scripps Research Inst Verfahren und zusammensetzungen zur verhinderung von entzündungen, die durch endothelzellen und fibrinogen ausgelöst werden
US5651970A (en) 1993-03-19 1997-07-29 Allen; Allen D. Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics
US5733540A (en) 1995-03-08 1998-03-31 Lee; Peter Poon-Hang Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria

Also Published As

Publication number Publication date
HK1047300A1 (zh) 2003-02-14
DE60042069D1 (de) 2009-06-04
US6566095B1 (en) 2003-05-20
WO2000079010A1 (en) 2000-12-28
CA2377479C (en) 2011-01-11
CN101912610A (zh) 2010-12-15
EP1190101A1 (de) 2002-03-27
ATE429518T1 (de) 2009-05-15
AU5885500A (en) 2001-01-09
JP2003513007A (ja) 2003-04-08
CN1402797A (zh) 2003-03-12
EP1190101B1 (de) 2009-04-22
JP4880153B2 (ja) 2012-02-22
CA2377479A1 (en) 2000-12-28
AU777241B2 (en) 2004-10-07
EP1190101A4 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
DK1157037T3 (da) GCSF-konjugater
TW200607798A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
AR023641A1 (es) Una composicion de copolimeros de propileno cristalinos, un procedimiento para prepararla, y una pelicula o lamina monocapa o multicapa que comprende adicha composicion
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
DK1239829T3 (da) Indretninger til indgivelse af medikamenter med antiprogestinegenskaber
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
IL172695A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
ES2135785T3 (es) Dispositivo de bloqueo temporal de dos partes de una pieza osea.
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
NO20006138L (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
DK0792149T3 (da) Orale præparater indeholdende ondansetron
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
TR200100054T2 (tr) Paroksetin metansülfonat
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
DK1190101T3 (da) Sammensætninger og fremgangsmåder til at forebygge transepithelial overförsel af HIV
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
DE69911023D1 (de) Antagonisten des gonadotropin freisetzenden hormons
EE05175B1 (et) Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis
NO20015338D0 (no) Androgenderivater og anvendelse derav
AR026637A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para uso en vacas gestantes
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
NO20014224D0 (no) 4-heterocyklysulfonamidyl-6-metoksy-5-(2-metoksy-fenoksy)-2- pyridyl-pyrimidinderivater, fremstilling derav og anvendelse somendotelin reseptor antagonister